| 000 | 02514 a2200817 4500 | ||
|---|---|---|---|
| 005 | 20250518041846.0 | ||
| 264 | 0 | _c20191030 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a2352-3026 | ||
| 024 | 7 |
_a10.1016/S2352-3026(19)30051-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Peng-Peng | |
| 245 | 0 | 0 |
_aAnthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial. _h[electronic resource] |
| 260 |
_bThe Lancet. Haematology _cJun 2019 |
||
| 300 |
_ae328-e337 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Grading |
| 650 | 0 | 4 |
_aNeutropenia _xetiology |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aFu, Di | |
| 700 | 1 | _aLi, Jian-Yong | |
| 700 | 1 | _aHu, Jian-Da | |
| 700 | 1 | _aWang, Xin | |
| 700 | 1 | _aZhou, Jian-Feng | |
| 700 | 1 | _aYu, Hao | |
| 700 | 1 | _aZhao, Xia | |
| 700 | 1 | _aHuang, Yao-Hui | |
| 700 | 1 | _aJiang, Lu | |
| 700 | 1 | _aLiu, Feng | |
| 700 | 1 | _aSu, Li-Ping | |
| 700 | 1 | _aChen, Zhuo-Wen | |
| 700 | 1 | _aZeng, Qing-Shu | |
| 700 | 1 | _aChen, Jie-Ping | |
| 700 | 1 | _aFang, Mei-Yun | |
| 700 | 1 | _aMa, Jun | |
| 700 | 1 | _aLiu, Ting | |
| 700 | 1 | _aSong, Yong-Ping | |
| 700 | 1 | _aYu, Kang | |
| 700 | 1 | _aLi, Yan | |
| 700 | 1 | _aQiu, Lu-Gui | |
| 700 | 1 | _aChen, Xie-Qun | |
| 700 | 1 | _aGu, Jian | |
| 700 | 1 | _aYan, Jin-Song | |
| 700 | 1 | _aHou, Ming | |
| 700 | 1 | _aHuang, Heng-Ye | |
| 700 | 1 | _aWang, Li | |
| 700 | 1 | _aCheng, Shu | |
| 700 | 1 | _aShen, Yang | |
| 700 | 1 | _aXiong, Hui | |
| 700 | 1 | _aChen, Sai-Juan | |
| 700 | 1 | _aZhao, Wei-Li | |
| 773 | 0 |
_tThe Lancet. Haematology _gvol. 6 _gno. 6 _gp. e328-e337 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2352-3026(19)30051-1 _zAvailable from publisher's website |
| 999 |
_c29727351 _d29727351 |
||